Effectiveness of ustekinumab dose escalation in Crohn’s disease patients with insufficient response to standard‐dose subcutaneous maintenance therapyUri Kopylov, David Drobne, Iria Bastón‐Rey et al.|Alimentary Pharmacology & Therapeutics|2020Cited by 80
<scp>CD</scp>73 is a phenotypic marker of effector memory <scp>T</scp>h17 cells in inflammatory bowel diseaseGlen Doherty, Simon C. Robson, Aiping Bai et al.|European Journal of Immunology|2012Cited by 64
Heightened Expression of CD39 by Regulatory T Lymphocytes Is Associated with Therapeutic Remission in Inflammatory Bowel DiseaseDavid Gibson, Elizabeth J. Ryan, Louise Elliott et al.|Inflammatory Bowel Diseases|2015Cited by 59